VDRM logo

ViaDerma, Inc. Stock Price

OTCPK:VDRM Community·US$246.7k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

VDRM Share Price Performance

US$0.0002
-0.01 (-96.88%)
US$0.0002
-0.01 (-96.88%)
Price US$0.0002

VDRM Community Narratives

There are no narratives available yet.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

ViaDerma, Inc. Key Details

US$44.7k

Revenue

US$7.1k

Cost of Revenue

US$37.6k

Gross Profit

US$1.6m

Other Expenses

-US$1.5m

Earnings

Last Reported Earnings
Dec 31, 2017
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About VDRM

Founded
2007
Employees
n/a
CEO
Christopher Otiko
WebsiteView website
viaderma.com

ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company’s lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.

Recent VDRM News & Updates

Recent updates

No updates